
Three tactics to set your employees at ease and to facilitate effective two-way discussions.

Three tactics to set your employees at ease and to facilitate effective two-way discussions.

A round-up of the latest products hitting the dermatology market including treatment for eczema and wounds, plus care for rejuvenating procedures.

A known oncogene previously associated with carcinomas of the breast, liver, ovaries, and colon appears to suppress the growth of melanoma cells, a team of researchers reported recently in Cell Reports.

Treatment for atopic dermatitis isn’t always straightforward. In this article, a physician outlines treatment approaches.

In this article, we take a look at the development of new treatments for atopic dermatitis.

Formulated with natural ingredients, emerginC’s vitamin C line, diminishes dark spots, brightens, and repairs sun-damaged skin.

Tattoos alter the skin’s ability to produce sweat and result in higher concentrations of sodium, a study shows.

“Because atopic dermatitis is episodic, its incidence, prevalence, persistence, remission, flare and long-term control require careful definition,” researchers write.

Almost seven in 10 consumers surveyed recently expressed interest in undergoing a cosmetic procedure, which is twice as many who considered such treatments in 2013, according to findings released by the American Society for Dermatologic Surgery (ASDS).

New recommendations from the International Eczema Council aim to address a question that has gone largely unanswered: When should dermatologists and others prescribe systemic therapy to treat atopic dermatitis?

The IL-23 inhibitor risankizumab was superior to ustekinumab in a phase two trial of adult patients with moderate-to-severe chronic plaque psoriasis, researchers report. (©FreeBirdPhotos/Shutterstock.com)

New research offers strong evidence that vascular inflammation and risk of having a major adverse cardiovascular event increases with psoriasis duration.

The U.S. Food and Drug Administration granted an expanded FDA 510(k) clearance in September for Cynosure’s non-invasive body contouring product, SculpSure.

The American Academy of Dermatology (AAD) is assisting with the Merit-based Incentive Payment System (MIPS) by offering a series of tools that guide users based on customized input.

Neither smart technology like digital pill caps, nor financial incentives, significantly improved patients’ medication adherence, a study shows.

Kyocera Communication Systems, a subsidiary of Kyocera, is teaming with the University of Tsukuba to created artificial intelligence (AI)-based technology that could identify skin cancers and other skin diseases.

Innovative Skincare has recently launched several new products to exfoliate, refresh, and rehydrate skin.

All teachers and mentors instruct; great ones inspire. They find ways to connect, challenge, compel and convince, motivating students to reach goals and make a difference.In their own words, five dermatologists share their appreciation for teachers and mentors who made a lasting impression.

Early trial results show a significant reduction of itch with the oral NK-1 antagonist serlopitant

Dupilumab plus topical corticosteroids safe and effective after failure of cyclosporine in moderate-to-severe atopic dermatitis

Oral propranolol is prescribed for the most serious cases. In this Lancet review, experts highlight some considerations for treatment.

Honoring the letter of minor consent laws requires respecting parents' wishes for oral contraceptives prescribed for acne.

EADV experts recommend six quality-of-life measures including the DLQI and Skindex-29 for acne treatment and research.

Words physicians use and how they say them influences the decisions patients make about treatment for actinic keratosis.

Expedited microneedle-assisted photodynamic therapy is a promising option for treatment of actinic keratoses.

All Calm™ Clinical Redness Corrector is formulated for redness, rosacea and sensitive skin, according to the company.

Staging cutaneous squamous cell skin cancer under AJCC-9 reveals more T3 cases.

Significant residual pigment may indicate elevated melanoma risk in atypical intraepidermal melanocytic proliferation (AIMP) lesions.

The October issue of Dermatology Times highlights advances in pediatric dermatology. This month we cover laser use in children, patch testing, data mining revelations in pediatric psoriasis.

Atopic dermatitis patients have a phobia of topical corticosteroids that is so strong, it’s been described as a “phenomenon.”